A novel Mouse Model of Jansen's Metaphyseal Chondrodysplasia for analyzing disease mechanisms and candidate therapeutics

被引:0
|
作者
Hoeppner, Jakob [1 ,2 ]
Firat, Damla [1 ,2 ]
Reyes, Monica [1 ,2 ]
Ramos-Torres, Karla [2 ,3 ]
Brugarolas, Pedro [2 ,3 ]
Yadav, Prem Swaroop [1 ,2 ]
Hanna, Patrick [1 ,2 ]
Wein, Marc [1 ,2 ]
Schipani, Ernestina [4 ]
Gardella, Thomas J. [1 ,2 ]
Jueppner, Harald [1 ,2 ]
机构
[1] Massachusetts Gen Hosp, Endocrine Unit, Boston, MA 02114 USA
[2] Harvard Med Sch, Boston, MA 02115 USA
[3] Massachusetts Gen Hosp, Dept Radiol, Gordon Ctr Med Imaging, Boston, MA 02114 USA
[4] Univ Penn, Perelman Sch Med, Dept Orthopaed Surg, Philadelphia, PA 19104 USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
1139
引用
收藏
页码:386 / 386
页数:1
相关论文
共 50 条
  • [31] Neurochemical Mechanisms of a Novel Alzheimer's Disease Therapeutics on Improvement of Cognition and Depressive Behavior
    Shioda, Norifumi
    Yamamoto, Yui
    Han, Feng
    Moriguchi, Shigeki
    Fukunaga, Kohji
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2011, 131 (04): : 505 - 511
  • [32] Novel Mechanisms of Spinal Cord Plasticity in a Mouse Model of Motoneuron Disease
    Gulino, Rosario
    Parenti, Rosalba
    Gulisano, Massimo
    BIOMED RESEARCH INTERNATIONAL, 2015, 2015
  • [33] Altered Brain Uptake of Therapeutics in a Triple Transgenic Mouse Model of Alzheimer's Disease
    Mehta, Dharmini C.
    Short, Jennifer L.
    Nicolazzo, Joseph A.
    PHARMACEUTICAL RESEARCH, 2013, 30 (11) : 2868 - 2879
  • [34] Altered Brain Uptake of Therapeutics in a Triple Transgenic Mouse Model of Alzheimer’s Disease
    Dharmini C. Mehta
    Jennifer L. Short
    Joseph A. Nicolazzo
    Pharmaceutical Research, 2013, 30 : 2868 - 2879
  • [35] A Mouse Model to Test Novel Therapeutics for Parkinson's Disease: an Update on the Thy1-aSyn ("line 61") Mice
    Richter, Franziska
    Stanojlovic, Milos
    Kaeufer, Christopher
    Gericke, Birthe
    Feja, Malte
    NEUROTHERAPEUTICS, 2023, 20 (01) : 97 - 116
  • [36] A Mouse Model to Test Novel Therapeutics for Parkinson’s Disease: an Update on the Thy1-aSyn (“line 61”) Mice
    Franziska Richter
    Milos Stanojlovic
    Christopher Käufer
    Birthe Gericke
    Malte Feja
    Neurotherapeutics, 2023, 20 (1) : 97 - 116
  • [37] Molecular Mechanisms and Therapeutics for SBMA/Kennedy's Disease
    Arnold, Frederick J.
    Merry, Diane E.
    NEUROTHERAPEUTICS, 2019, 16 (04) : 928 - 947
  • [38] Mitochondrial mechanisms in Alzheimer?s disease: Quest for therapeutics
    Kalani, Komal
    Chaturvedi, Poonam
    Chaturvedi, Pankaj
    Verma, Vinod Kumar
    Lal, Nand
    Awasthi, Sudhir K.
    Kalani, Anuradha
    DRUG DISCOVERY TODAY, 2023, 28 (05)
  • [39] Experimental therapeutics in mouse models of Huntington's disease
    Hockly, E
    Lupton, MK
    Sunshine, S
    Tse, J
    Woodman, B
    Bates, GP
    Revington, AP
    Lowden, PAS
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2005, 76
  • [40] Molecular Mechanisms and Therapeutics for SBMA/Kennedy’s Disease
    Frederick J. Arnold
    Diane E. Merry
    Neurotherapeutics, 2019, 16 : 928 - 947